CBWTF - Auxly Cannabis Group Inc. (OTCPK) - Share Price and News

Auxly Cannabis Group Inc.
US ˙ OTCPK ˙ CA05335P1099

Overview
Auxly Cannabis Group Inc., based in Canada, operates primarily within the cannabis industry, focusing on the cultivation, extraction, and distribution of cannabis products. A key player in the development and innovation of cannabis-derived products, Auxly emphasizes a vertically integrated approach, overseeing operations from seed to sale. This enables stringent control over their product quality, aligning with market and regulatory demands. Auxly's portfolio spans various segments including recreational, medicinal, and wellness categories, delivering diverse products such as dried flowers, oils, and edibles. Key projects include strategic partnerships and participation in research aimed at product development and market expansion. This orchestrated strategy is designed to enhance their market presence and ensure sustainable growth within the evolving cannabis industry.
AI+ Ask Fintel’s AI assistant about Auxly Cannabis Group Inc..
Thinking about good questions…
Basic Stats

The share price of Auxly Cannabis Group Inc. as of June 11, 2024 is $0.02 / share. The market cap (or net worth) of Auxly Cannabis Group Inc. as of September 5, 2025 is $29.00 MM.

The Factor Analysis chart (below right) shows a view of Auxly Cannabis Group Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.

For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.

Market Cap 29.00 MM
EV
Shares Out. 1,318.19 MM
Earnings Date
EPS (TTM) 0.02
Dividend Yield
Ex-Dividend Date
Borrow Rate 1.52
Short Shares Avail. 4.60 MM
Short Interest
Short Float
Days to Cover
Risk Free Rate 4.17 %
Price Change (1 yr)
Volatility (1 yr)
Beta
Sharpe Ratio (1 yr)
Sortino Ratio (1 yr)
PE Ratio
Price/Book
Price/TBV
Book/Market
EBIT/EV
EBIT(3yr avg)/EV
ROA 0.11
ROE 0.26
ROIC 0.14
CROIC 0.01
OCROIC 0.11
Implied Volatility
Put/Call OI Ratio
Growth
Profitability
Quality Score
Value Score
Momentum Score
Stability (Low Vol) Score
Analyst Sentiment
Fund Sentiment
Insider Sentiment
Officer Sentiment
Dividend Score
QVM Score
Piotroski F-SCORE 6.00 /9
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target

The average one-year price target for Auxly Cannabis Group Inc. is $0.01. The forecasts range from a low of $0.01 to a high of $0.01. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2024-08-06 2025-08-06 0.01 0.01 0.01 0.01
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Auxly Cannabis Group Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Date Analyst Prior Latest
Recommendation
Action
2023-08-21 RESEARCH CAPITAL CORPORATION Hold Hold Maintains
2023-08-20 RESEARCH CAPITAL CORPORATION Hold Hold Maintains
2023-05-15 RESEARCH CAPITAL CORPORATION Buy Hold Downgrade
2023-05-14 RESEARCH CAPITAL CORPORATION Buy Hold Downgrade
2023-04-04 RESEARCH CAPITAL CORPORATION Buy Hold Downgrade
2022-11-28 CANTOR FITZGERALD Overweight Neutral Downgrade
2022-11-27 CANTOR FITZGERALD Overweight Neutral Downgrade
2022-11-14 RAYMOND JAMES LTD. Outperform Outperform Maintains
2022-11-14 RESEARCH CAPITAL CORPORATION Buy Buy Maintains
2022-11-13 RAYMOND JAMES LTD. Outperform Outperform Maintains
2022-11-13 RESEARCH CAPITAL CORPORATION Buy Buy Maintains
2022-08-15 ATB CAPITAL MARKETS Outperform Outperform Maintains
2022-08-14 ATB CAPITAL MARKETS Outperform Outperform Maintains
2022-07-25 CANTOR FITZGERALD Overweight Overweight Maintains
2022-07-24 CANTOR FITZGERALD Overweight Overweight Maintains
2022-05-13 RAYMOND JAMES LTD. Outperform Outperform Maintains
2022-05-12 RAYMOND JAMES LTD. Outperform Outperform Maintains
2022-04-03 RESEARCH CAPITAL CORPORATION Buy Buy Maintains
2022-04-02 RESEARCH CAPITAL CORPORATION Buy Buy Maintains
2022-03-28 Raymond James Capital Outperform Maintains
2022-02-09 DESJARDINS SECURITIES Buy Buy Maintains
2022-02-08 DESJARDINS SECURITIES Buy Buy Maintains
2021-11-29 RaymondJamesFinancial Outperform Initiate
2021-08-17 Raymond James Financial Outperform Initiate
2021-05-31 Raymond James Financial Market Perform Initiate
2021-05-28 DESJARDINS SECURITIES Buy Buy Maintains
2021-05-27 DESJARDINS SECURITIES Buy Buy Maintains
Other Listings
CA:XLY CA$0.14
DE:3KF €0.09
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista